The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Burow Kristina | Director | Sell(S) | 2K | $53.49 | $113K |
| Jul 1, 2026 | Burow Kristina | Director | Sell(S) | 948 | $54.28 | $51K |
| Jul 1, 2026 | Flier Jeffrey S. | Director | Sell(S) | 2K | $53.53 | $84K |
| Jul 1, 2026 | Flier Jeffrey S. | Director | Sell(S) | 1K | $54.24 | $80K |
| Jul 1, 2026 | Flier Jeffrey S. | Director | Sell(S) | 15 | $54.88 | $823 |
| Jul 1, 2026 | Gilman Michael | Director | Sell(S) | 1K | $53.54 | $72K |
| Jul 1, 2026 | Gilman Michael | Director | Sell(S) | 1K | $54.23 | $63K |
| Jul 1, 2026 | Gilman Michael | Director | Sell(S) | 43 | $54.81 | $2K |
| Jul 1, 2026 | Peng Katie | Director | Sell(S) | 3K | $53.56 | $160K |
| Jul 1, 2026 | Peng Katie | Director | Sell(S) | 2K | $54.25 | $132K |
| Jul 1, 2026 | Peng Katie | Director | Sell(S) | 21 | $54.96 | $1K |
| Jul 1, 2026 | Reed Joshua | Director | Sell(S) | 2K | $53.50 | $113K |
| Jul 1, 2026 | Reed Joshua | Director | Sell(S) | 948 | $54.28 | $51K |
| Jun 4, 2026 | Akkaraju Srinivas | Director | Grant(A) | 7K | — | $0 |
| Jun 4, 2026 | Akkaraju Srinivas | Director | Grant(A) | 4K | — | $0 |
| Jun 4, 2026 | Flier Jeffrey S. | Director | Grant(A) | 7K | — | $0 |
| Jun 4, 2026 | Flier Jeffrey S. | Director | Grant(A) | 4K | — | $0 |
| Jun 4, 2026 | Reed Joshua | Director | Grant(A) | 7K | — | $0 |
| Jun 4, 2026 | Reed Joshua | Director | Grant(A) | 4K | — | $0 |
| Jun 4, 2026 | Brudnick Richard | Director | Grant(A) | 7K | — | $0 |
| Jun 4, 2026 | Brudnick Richard | Director | Grant(A) | 4K | — | $0 |
| Jun 4, 2026 | Burow Kristina | Director | Grant(A) | 7K | — | $0 |
| Jun 4, 2026 | Burow Kristina | Director | Grant(A) | 4K | — | $0 |
| Jun 4, 2026 | Gilman Michael | Director | Grant(A) | 7K | — | $0 |
| Jun 4, 2026 | Gilman Michael | Director | Grant(A) | 4K | — | $0 |
| Jun 4, 2026 | Peng Katie | Director | Grant(A) | 7K | — | $0 |
| Jun 4, 2026 | Peng Katie | Director | Grant(A) | 4K | — | $0 |
| Apr 23, 2026 | Burow Kristina | Director | Option exercise(M) | 8K | $26.78 | $209K |
| Apr 23, 2026 | Burow Kristina | Director | Option exercise(M) | 28K | $4.75 | $133K |
| Apr 23, 2026 | Burow Kristina | Director | Option exercise(M) | 36K | $9.11 | $328K |
| Apr 23, 2026 | Burow Kristina | Director | Option exercise(M) | 18K | $8.36 | $150K |
| Apr 23, 2026 | Burow Kristina | Director | Option exercise(M) | 8K | — | $0 |
| Apr 23, 2026 | Burow Kristina | Director | Option exercise(M) | 28K | — | $0 |
| Apr 23, 2026 | Burow Kristina | Director | Option exercise(M) | 36K | — | $0 |
| Apr 23, 2026 | Burow Kristina | Director | Option exercise(M) | 18K | — | $0 |
| Apr 16, 2026 | Hallal David | Chief Executive Officer, Director | Sell(S) | 31K | $49.57 | $1.5M |
| Apr 16, 2026 | Sinha Vikas | Chief Financial Officer | Sell(S) | 10K | $49.57 | $516K |
| Apr 16, 2026 | Vaishnaw Akshay | President of R&D, Director | Sell(S) | 12K | $49.57 | $607K |
| Apr 16, 2026 | Woods Keith | Chief Operating Officer | Sell(S) | 10K | $49.57 | $507K |
| Feb 23, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Sell(S) | 7K | $46.94 | $349K |
| Feb 23, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Sell(S) | 200 | $48.48 | $10K |
| Feb 23, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Sell(S) | 857 | $47.86 | $41K |
| Feb 17, 2026 | Marantz Jing L. | CHIEF MEDICAL OFFICER | Sell(S) | 4K | $46.53 | $193K |
| Feb 17, 2026 | Ho Junlin | GENERAL COUNSEL | Sell(S) | 10K | $46.53 | $446K |
| Feb 17, 2026 | Parlavecchio Caryn | CHRO | Sell(S) | 9K | $46.53 | $420K |
| Feb 17, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Sell(S) | 8K | $46.53 | $372K |
| Feb 9, 2026 | Woods Keith | Chief Operating Officer | Grant(A) | 47K | — | $0 |
| Feb 9, 2026 | Hallal David | Chief Executive Officer, Director | Grant(A) | 128K | — | $0 |
| Feb 9, 2026 | Ho Junlin | General Counsel | Grant(A) | 37K | — | $0 |
| Feb 9, 2026 | Marantz Jing L. | Chief Medical Officer | Grant(A) | 34K | — | $0 |
| Feb 9, 2026 | Parlavecchio Caryn | Chief Human Resources Officer | Grant(A) | 29K | — | $0 |
| Feb 9, 2026 | Qatanani Mo | Chief Scientific Officer | Grant(A) | 29K | — | $0 |
| Feb 9, 2026 | Sinha Vikas | Chief Financial Officer | Grant(A) | 47K | — | $0 |
| Feb 9, 2026 | Vaishnaw Akshay | President of R&D, Director | Grant(A) | 47K | — | $0 |
| Jan 22, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Sell(S) | 2K | $45.87 | $97K |
| Jan 22, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Sell(S) | 13K | $46.85 | $599K |
| Jan 16, 2026 | Marantz Jing L. | CHIEF MEDICAL OFFICER | Sell(S) | 6K | $44.48 | $258K |
| Jan 16, 2026 | Ho Junlin | GENERAL COUNSEL | Sell(S) | 8K | $44.48 | $357K |
| Jan 16, 2026 | Parlavecchio Caryn | CHRO | Sell(S) | 7K | $44.48 | $294K |
| Jan 16, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Sell(S) | 8K | $44.48 | $374K |
| Jan 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Sell(S) | 13K | $45.20 | $593K |
| Jan 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 3K | $35.15 | $94K |
| Jan 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 1K | $18.08 | $25K |
| Jan 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 6K | $15.75 | $93K |
| Jan 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 3K | $10.00 | $28K |
| Jan 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 321 | $7.62 | $2K |
| Jan 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 1K | — | $0 |
| Jan 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 3K | — | $0 |
| Jan 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 6K | — | $0 |
| Jan 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 3K | — | $0 |
| Jan 14, 2026 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 321 | — | $0 |
| Jan 13, 2026 | Hallal David | Chief Executive Officer, Director | Sell(S) | 57K | $42.70 | $2.5M |
| Jan 13, 2026 | Vaishnaw Akshay | President of R&D, Director | Sell(S) | 20K | $42.70 | $873K |
| Jan 13, 2026 | Woods Keith | Chief Operating Officer | Sell(S) | 17K | $42.70 | $715K |
| Jan 13, 2026 | Sinha Vikas | Chief Financial Officer | Sell(S) | 17K | $42.70 | $715K |
| Dec 16, 2025 | Peng Katie | Director | Sell(S) | 726 | $43.88 | $32K |
| Dec 16, 2025 | Peng Katie | Director | Sell(S) | 280 | $44.63 | $12K |
| Dec 12, 2025 | Akkaraju Srinivas | Director | Option exercise(X) | 1.1M | $7.35 | $7.8M |
| Dec 12, 2025 | Akkaraju Srinivas | Director | Option exercise(X) | 1.1M | — | $0 |
| Dec 11, 2025 | Siren, L.L.C. | 10% Owner | Option exercise(X) | 1.6M | $7.35 | $11.6M |
| Dec 11, 2025 | Siren, L.L.C. | 10% Owner | Option exercise(X) | 1.6M | — | $0 |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 21K | $18.08 | $381K |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 6K | $4.86 | $27K |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 1K | $7.62 | $10K |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 11K | $10.00 | $113K |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 8K | $35.15 | $282K |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Sell(S) | 136K | $45.21 | $6.2M |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 66K | $26.05 | $1.7M |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 24K | $15.75 | $371K |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 66K | — | $0 |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 8K | — | $0 |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 24K | — | $0 |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 11K | — | $0 |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 1K | — | $0 |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 6K | — | $0 |
| Dec 4, 2025 | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 21K | — | $0 |
| Oct 8, 2025 | Hallal David | Chief Executive Officer, Director | Gift(G) | 205K | — | $0 |
| Oct 7, 2025 | Akkaraju Srinivas | Director | Buy(P) | 4K | $40.97 | $180K |
| Oct 7, 2025 | Akkaraju Srinivas | Director | Buy(P) | 13K | $39.31 | $503K |
| Oct 7, 2025 | Akkaraju Srinivas | Director | Buy(P) | 12K | $40.18 | $498K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).